Morning Movers 05/11: (GWAY) (RPRX) (MDR) Higher; (ADY) (ALR) (ASYS) (WAVX) Lower
Tweet
Share
E-mail
Get Alerts GWAY Hot Sheet
Join SI Premium – FREE
Greenway Medical Technologies (NYSE: GWAY) 25.5% HIGHER; reported Q3 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $32.9 million versus the consensus estimate of $28.54 million.
Feihe International (NYSE: ADY) 20% LOWER; traders are taking some profits following a 49 percent rise yesterday on the heels of strong Q1 results.
Alere Inc. (NYSE: ALR) 18% LOWER; is getting hit early after issuing the following disclousure in an SEC filing. Click here to see full details. The stock was also downgraded at Leerink Swann.
Amtech Systems (NASDAQ: ASYS) 16.8% LOWER; reported Q2 EPS of ($0.54), $0.32 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $21.55 million. Sees FY2012 revenue of $18-$20 million, versus the consensus of $27 million.
Repros Therapeutics (Nasdaq: RPRX) 14.7% HIGHER; stock is continuing higher today following news the company and the FDA reached an agreement on the Androxal(R) registration program and the resulting 31.5% rise yesterday.
Wave Systems Corp. (NASDAQ: WAVX) 14.5% LOWER; posted a loss of 9 cents per share vs. a 3 cent per share loss for the same period last year. Total net revenue was $7.0 million, compared with $7.5 million in Q1 '11 and $11.0 million in Q4 '11.
McDermott International, Inc. (NYSE: MDR) 14.4% HIGHER; reported Q1 EPS of $0.25, $0.10 better than the analyst estimate of $0.15. Revenue for the quarter came in at $727.7 million versus the consensus estimate of $834.83 million.
Roundys (NYSE: RNDY) 14.3% LOWER; reported Q1 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $938.2 million versus the consensus estimate of $929.4 million.
Career Education Corp (NASDAQ: CECO) 13.6% LOWER; reported Q1 EPS of $0.69 vs. the analyst estimate of $0.25 (may not compare). Revenue for the quarter came in at $434.1 million versus the consensus estimate of $429.57 million.
Keryx Biopharma (Nasdaq: KERX) 12.1% HIGHER; the stock is continuing higher following a 13 percent yesterday amid several upgrades.
Kemet (NYSE: KEM) 11.2% LOWER; BofA/Merrill Lynch downgraded the stock from Buy to Underperform.
Osiris Therapeutics (NASDAQ: OSIR) 11% HIGHER; reported Q1 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.45 million.
Orexigen (Nasdaq: OREX) 10.7% HIGHER; Arena won FDA panel backing for its lorcaserin drug candidate.
Pacific Ethanol (NASDAQ: PEIX) 10.7% LOWER; reported Q1 EPS of ($0.06), versus ($0.02) reported last year. Revenue for the quarter came in at $197.7 million versus the consensus estimate of $173 million.
WuXi PharmaTech (NYSE: WX) 10.5% HIGHER; reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $118 million versus the consensus estimate of $114.19 million. Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.
Air Transport Services Group, Inc. (NASDAQ: ATSG) 10.1% HIGHER; reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $145.5 million versus the consensus estimate of $151.94 million.
Leap Wireless International Inc. (Nasdaq: LEAP) 10% HIGHER; reports from Reuters said AT&T (NYSE: T) held talks to buy the company recently.
Feihe International (NYSE: ADY) 20% LOWER; traders are taking some profits following a 49 percent rise yesterday on the heels of strong Q1 results.
Alere Inc. (NYSE: ALR) 18% LOWER; is getting hit early after issuing the following disclousure in an SEC filing. Click here to see full details. The stock was also downgraded at Leerink Swann.
Amtech Systems (NASDAQ: ASYS) 16.8% LOWER; reported Q2 EPS of ($0.54), $0.32 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $21.55 million. Sees FY2012 revenue of $18-$20 million, versus the consensus of $27 million.
Repros Therapeutics (Nasdaq: RPRX) 14.7% HIGHER; stock is continuing higher today following news the company and the FDA reached an agreement on the Androxal(R) registration program and the resulting 31.5% rise yesterday.
Wave Systems Corp. (NASDAQ: WAVX) 14.5% LOWER; posted a loss of 9 cents per share vs. a 3 cent per share loss for the same period last year. Total net revenue was $7.0 million, compared with $7.5 million in Q1 '11 and $11.0 million in Q4 '11.
McDermott International, Inc. (NYSE: MDR) 14.4% HIGHER; reported Q1 EPS of $0.25, $0.10 better than the analyst estimate of $0.15. Revenue for the quarter came in at $727.7 million versus the consensus estimate of $834.83 million.
Roundys (NYSE: RNDY) 14.3% LOWER; reported Q1 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $938.2 million versus the consensus estimate of $929.4 million.
Career Education Corp (NASDAQ: CECO) 13.6% LOWER; reported Q1 EPS of $0.69 vs. the analyst estimate of $0.25 (may not compare). Revenue for the quarter came in at $434.1 million versus the consensus estimate of $429.57 million.
Keryx Biopharma (Nasdaq: KERX) 12.1% HIGHER; the stock is continuing higher following a 13 percent yesterday amid several upgrades.
Kemet (NYSE: KEM) 11.2% LOWER; BofA/Merrill Lynch downgraded the stock from Buy to Underperform.
Osiris Therapeutics (NASDAQ: OSIR) 11% HIGHER; reported Q1 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.45 million.
Orexigen (Nasdaq: OREX) 10.7% HIGHER; Arena won FDA panel backing for its lorcaserin drug candidate.
Pacific Ethanol (NASDAQ: PEIX) 10.7% LOWER; reported Q1 EPS of ($0.06), versus ($0.02) reported last year. Revenue for the quarter came in at $197.7 million versus the consensus estimate of $173 million.
WuXi PharmaTech (NYSE: WX) 10.5% HIGHER; reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $118 million versus the consensus estimate of $114.19 million. Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.
Air Transport Services Group, Inc. (NASDAQ: ATSG) 10.1% HIGHER; reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $145.5 million versus the consensus estimate of $151.94 million.
Leap Wireless International Inc. (Nasdaq: LEAP) 10% HIGHER; reports from Reuters said AT&T (NYSE: T) held talks to buy the company recently.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- Direct Digital Holdings (DRCT) Receives Nasdaq Non-compliance Notice
- Cyngn Inc (CYN) Announces Pricing of $5.0 Million Firm Commitment Public Offering of Common Stock
Create E-mail Alert Related Categories
Special ReportsRelated Entities
American Technology Research, Morning Movers, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
